Haemodialysis and renal transplantation are acceptable treatments for older children and adolescents with end stage renal disease. However, many paediatric nephrologists hesitate to recommend such treatment for young children and infants.
Reports of renal transplants in children under age 5 years are rare and results are sometimes discouraging. [1] [2] [3] [4] [5] [6] [7] [8] In 1978 Hodson and co-workers7 reported a large series of renal transplants from 19 related live donors (LD) and 4 cadaver donors (CD) in children less than 5 years old. Their results were similar to those for older children. We now give our experience with 31 renal transplants performed in 19 children under age 5 years. Most of the allografts were from cadaver donors.
Materials and methods
Between September 1968 and March 1979, 19 children (aged between 11 months and 5 years 1 month) received 31 renal allografts from 4 LD and 27 CD. 10 recipients received one allograft, 7 received two, 1 received three, and 1 received four allografts. Eight recipients were girls and 11 were boys. The average age at the time of the initial transplant was 3 years 1 month; 2 infants were 11 months.
The primary renal diseases of the 19 children were: focal glomerulosclerosis (3), membranoproliferative glomerulonephritis (2), obstructive uropathy (4), hypoplastic or dysplastic kidneys, or both, (3), haemolytic uraemic syndrome (2), cortical necrosis (1), medullary cystic disease (1), polycystic kidney disease with congenital hepatic fibrosis (1), infantile nephrotic syndrome (1), and bilateral Wilms's tumour (1) .
Haemodialysis was started before transplantation in 17 patients and 2 children were treated with peritoneal dialysis.9 The average time of dialysis before initial transplantation was 5 months (range 5 days to 13 months). Bilateral nephrectomy was performed before transplantation in 6 recipients, and simultaneously with transplantation in 3 recipients. The remaining 10 recipients did not undergo bilateral nephrectomy.
During the period of dialysis each patient received at least one blood transfusion (mean 9 * 7; range 1-30 units). Despite the blood transfusion (stored sedimented red blood cells) only 2 patients had preformed lymphocytotoxic antibodies before receiving their initial allografts.
The ages of the donors of the 27 CD allografts were > 12 years in ten cases, between 4 and 6 years in four, and <2 years in nine cases. All 4 LD allografts were from mothers who were between 27 and 30 years of age.
An extraperitoneal approach, with placement of the allograft in the iliac fossa as previously de- scribed,10 was used in each instance. The 10 recipients with functioning allografts is 0 3 to 6-0 mg/100 ml (26.5 to 530 ,umol/l) with 8 receipients having a serum creatinine level <1-0 mg/100 ml (<88-4 ,umol/l). The low serum creatinine levels in these young children did not influence the prompt diagnosis of rejection episodes. The 1-and 2-year actuarial patient survival (± SEM) was 83 ± 9% and 75 ± 11% respectively.
Two children died within the first month after their transplants, during the period when the CD allograft was recovering from acute tubular necrosis. One Immunological factors accounted for two-thirds of the allograft failures in the present series. This incidence is similar to that in a large series.'0 The nonimmunological causes of allograft loss were possibly related to recipient age. However, it is difficult definitively to implicate the recipients' age in the 3 technical failures or the 4 patient deaths. Two of the 3 technical failures could be related to donor age; however, anencephalic kidneys2' and kidneys from donors aged under 6 months have been used successfully.'0 Since the recipients were managed in a paediatric institution experienced in the care of end stage renal disease, it is assumed that the nonimmunological failures were not attributable to unfamiliarity with general paediatric care.
The poor outcome of CD allografts indicates the need to justify this treatment for young children. Hodson et al.,7 suggested that 'when possible, this should be carried out using living related donor kidneys, thus avoiding long periods of dialysis, which in the small child is frequently associated with vascular access problems, malnutrition, and progressive renal osteodystrophy'. The problems encountered in dialysing small children are often difficult to manage; however, the criteria for donor selection should be based on predictability of improved outcome. Although current data on allografts show that LD is optimum regardless of recipient age, it must be remembered that nearly half of the CD recipients are currently surviving with functioning allografts. Therefore, the availability of a LD should not be a prerequisite for initiating treatment for end stage renal disease.
In addition to outcome, the two factors which should be considered before selecting a donor are growth and rehabilitation after transplantation. Hodson et al., in 1978,7 reported that most LD allograft recipients who survived with functioning allografts for longer than 6 months demonstrated catch-up growth. However, few recipients maintained catch-up growth during the second and third years after their transplants.
The long-term results of linear growth in young children cannot be determined from the present series. However, catch-up or normal linear growth was observed in the 3 LD allograft recipients whereas similar growth was observed in only 3 of the CD allograft recipients. In at least 2 instances, poor CD allograft function contributed to reduced growth velocity.22 Introduction of alternate day therapy has had a salutory effect on linear growth, but further data are needed in order to determine the effect of alternate day therapy on adult height. less than 5 years of age. 
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